Georgetown University
Georgetown University
Explore linked clinical trials.73 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-10-09 | NCT07439172 | |
| The INTERvening for LUNG Health Trial | Spirometry | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07540000 | |
| A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-10-07 | NCT04675476 | |
| RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Not yet recruiting | Phase 2 | 2026-10-06 | NCT07645326 | |
| Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-10-06 | NCT06449313 | |
| Evaluating Novel Therapies in ctDNA Positive GI Cancers | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, colon adenocarcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder adenocarcinoma, gastric adenocarcinoma, hepatocellular carcinoma, intestinal disorder, liver disorder, neoplasm, pancreatic adenocarcinoma, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Active, not recruiting | Phase 3 | 2026-10-06 | NCT05482516 | |
| SBRT for Ultra-Central NonSmall Cell Lung Cancer | Nonsmall Cell Lung Cancer Stage | Not yet recruiting | Phase 1 | 2026-10-01 | NCT07852247 | |
| Hard Cervical Collar Use Following Posterior Cervical Fusion | bone disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, radiculopathy, spondylosis, vertebral column disorder | Recruiting | Not applicable | 2026-10-01 | NCT07789288 | |
| Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2026-09-30 | NCT06423326 | |
| Older Breast Cancer Patients: Risk for Cognitive Decline | Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cognitive disorder, neoplasm, psychiatric disorder, skin disorder | Recruiting | Not stated | 2026-09-28 | NCT03451383 | |
| RESvEraTrol in Parkinson's Disease (RESET) | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-09-18 | NCT07592767 | |
| Home-based Vision Rehabilitation Guided by Brain Imaging | Brain Injuries, Traumatic, Craniocerebral Trauma, Hemianopsia, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Quadrantanopsia, Sensation Disorders, Signs and Symptoms, blindness (disorder), brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, cortical blindness, eye disorder, injury, neoplasm, nervous system disorder, nervous system injury, stroke disorder, vascular disorder, vision disorder | Recruiting | Not applicable | 2026-09-14 | NCT07635329 | |
| Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training | Brain Injuries, Traumatic, Craniocerebral Trauma, Hemianopsia, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Quadrantanopsia, Sensation Disorders, Signs and Symptoms, blindness (disorder), brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, cortical blindness, eye disorder, injury, neoplasm, nervous system disorder, nervous system injury, stroke disorder, vascular disorder, vision disorder | Recruiting | Not applicable | 2026-09-14 | NCT07105358 | |
| BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Ductal Adenocarcinoma | Active, not recruiting | Phase 2 | 2026-09-14 | NCT05558982 | |
| A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 2 | 2026-09-11 | NCT06248515 | |
| Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-09-10 | NCT04958811 | |
| Pembrolizumab and Lenvatinib in Advanced Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 | 2026-09-10 | NCT04865887 | |
| TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT03964532 | |
| Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity | Chronic Disease, Chronic Kidney Diseases, Cognition Disorders, Cognitive Dysfunction, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Mild Cognitive Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, cognitive disorder, kidney disorder, kidney failure, psychiatric disorder, urinary system disorder | Recruiting | Not applicable | 2026-09-08 | NCT05655325 | |
| Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-08-26 | NCT05334732 | |
| MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-08-20 | NCT07644598 | |
| Metformin in Alzheimer's Dementia Prevention | Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-08-11 | NCT04098666 | |
| Rural Adult and Youth Sun Protection Study | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not applicable | 2026-08-10 | NCT06439979 | |
| Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis | Digestive System Diseases, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, pancreas disorder, pancreatitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT05551858 | |
| Mosaic Trial for Stem Cell Transplant Recipients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, bone marrow disorder, cardiovascular disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myelodysplastic syndrome, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not applicable | 2026-08-03 | NCT06960993 |